LONDON, Nov. 20, 2017 /PRNewswire/ --
"Global tissue diagnostics market projected to grow at a CAGR of 6.9% during the forecast period"
Download the full report: https://www.reportbuyer.com/product/5206184The tissue diagnostics market is expected to reach USD 5.14 billion by 2022 from USD 3.68 billion in 2017, at
a CAGR of 6.9%. Factors driving the growth of this market include the rising incidence of cancer, growing healthcare expenditure, improving infrastructure for cancer diagnosis, and technological advancements in tissue diagnostics. On the other hand, complex regulatory frameworks that delay the approval of new diagnostic products and lack of infrastructure are expected to challenge market growth to a certain extent. "The breast cancer segment is anticipated to grow at the fastest growth rate during the forecast period"
The tissue diagnostics market by disease, is categorized into breast cancer, gastric cancer, lymphoma, prostate cancer, NSCLC, and other diseases. The breast cancer segment is expected to grow at the highest CAGR during the forecast period. The growing use of tissue diagnostics for the diagnosis of breast cancer, increasing awareness regarding breast cancer, and the development of novel products are the key factor driving the growth of this market. "The research laboratories segment is estimated to grow at a rapid rate during the analysis period"
By end user, the tissue diagnostics market is segmented into hospitals, pharmaceutical companies, research laboratories, contract research organizations, and other end users. The research laboratories segment is expected to remain the fastest-growing segment of the global tissue diagnostics market during the forecast period. Factors such as the rising number of cancer drug trials and growing research activities to design novel biomarkers for tissue diagnosis are driving the growth of this segment. "Asia is estimated to grow at the highest CAGR during the study period"
Geographically, the tissue diagnostics market is dominated by North America, followed by Europe in 2017, however, Asia is estimated to grow at the fastest rate during the forecast period. Growth in this region can be attributed to developing healthcare infrastructure, rising burden of cancer, and increasing initiatives to promote the use of novel technologies for tissue diagnostics in Asian countries. The primary interviews conducted for this report can be categorized as follows:
• By Company Type - Tier 1 – 70% and Tier 2 – 30% • By Designation – C level – 62%, Director level – 21%, Others – 17% • By Region – North America – 50%, Europe – 20%, Asia– 30% The key players in the tissue diagnostics market include Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), Merck (Germany), Sakura Finetek Japan (Japan), Abcam (UK), BD (US), QIAGEN (Netherlands), Sienna Cancer Diagnostics (Australia), Royal Philips (Netherlands), A. Menarini Diagnostics (Italy), Cell Signaling Technology (US), Enzo Life Sciences (US), Master Diagnóstica (Spain), TissueGnostics (Austria), Bio SB (US), MedImmune (US), Cernostics (US), Zenalux Biomedical (US), 3DHISTECH (Hungary), Lunaphore Technologies (Switzerland), BioGenex (US), and Biocare Medical (US). Research Coverage:
The report analyses the tissue diagnostics market by product, technology, disease, end user, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market. Key benefits of buying the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares. The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the tissue diagnostics market • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the tissue diagnostics market • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the tissue diagnostics market • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various tissue diagnostics products and services across geographies • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the tissue diagnostics marketDownload the full report: https://www.reportbuyer.com/product/5206184
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith
Research Advisor at Reportbuyer.com Email: firstname.lastname@example.org
Tel: +44 208 816 85 48 Website: www.reportbuyer.com
View original content:http://www.prnewswire.com/news-releases/tissue-diagnostics-market-by-product-technology-disease-end-user---global-forecast-to-2022-300559939.html